ESCAPE Bio Funding & Investors
Escape Bio, Inc. operates as a preclinical stage biopharmaceutical company. The Company discovers and develops small molecule drugs and medicines to treat genetically-defined subpopulations in neurodegenerative diseases. Escape Bio serves customers in the State of California.
escapebio.comTotal Amount Raised: $187,076,080
ESCAPE Bio Funding Rounds
Series B
$73,000,000
Series B Investors
Wellington ManagementSurveyor CapitalAvidity PartnersCAM CapitalNew Leaf VenturesJohnson & Johnson Innovation – JJDCOsage University Partners (OUP)OrbiMed AdvisorsNovartis Venture FundNovo HoldingsSphera Funds ManagementSutter Hill VenturesRock Springs CapitalSeries Unknown
$31,073,380
Series A
$63,000,000
Series A Investors
OrbiMed AdvisorsNovo HoldingsJohnson & Johnson Robotics and Digital SolutionsNovartis Venture FundOsage University Partners (OUP)Sutter Hill VenturesSeries Unknown
$20,002,700
Funding info provided by Diffbot.